FDA dusts off dispute panel for Cardima hearing in late 2006
This article was originally published in Clinica
Executive Summary
The US FDA has agreed to convene its rarely-used medical devices dispute resolution panel (MDDRP) to air the concerns of the cardiology company Cardima.